A Pilot Randomized Controlled Trial for Hand Osteoarthritis
Primary Purpose
Hand Osteoarthritis
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Hand orthosis
Sponsored by
About this trial
This is an interventional treatment trial for Hand Osteoarthritis
Eligibility Criteria
Inclusion Criteria:
- Enrolled to receive medical care at the Michael E. DeBakey VA Medical Center
- At least 3 joints affected by distal interphalangeal (DIP) nodal hand OA
- DIP nodal hand OA will be defined as Heberden's nodes on physical exam.
- Sufficiently severe frequent pain of at least one DIP
- Frequent pain: pain on most days of the month for at least one month in the last year.
- Minimum VAS pain severity of 40 on a 0 - 100 scale
Exclusion Criteria:
- History or current inflammatory arthritides (examples: gout, psoriatic arthritis, and rheumatoid arthritis)
- Prior surgery on the DIP joints
- Planned surgery for the DIP joints
- Pregnancy
Sites / Locations
- NYU LangoneRecruiting
- Michael E. DeBakey VA Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Treatment arm with control orthosis
Treatment arm with experimental orthosis
Arm Description
Outcomes
Primary Outcome Measures
Visual analog scale (VAS) for pain in the more symptomatic hand that includes the most symptomatic DIP joint by 24 weeks of use of traction therapy with standard of care treatment for hand OA to establish efficacy of traction therapy.
An assessment of pain intensity in a given hand.
The primary structure endpoint will be change in sum of the Kellgren and Lawrence score of all Distal InterPhalangeal Joints in the hand that was placed in an orthosis over 24 weeks.
An assessment of radiographic OA severity.
Secondary Outcome Measures
The Functional Index for Hand Osteoarthritis (FIHOA)
An assessment of hand function
The Disabilities of Arm Shoulder and Hand (DASH)
An assessment of hand disability
Functional Dexterity Test
An assessment of hand functional dexterity
Grip Strength
An assessment of the amount of force that can be applied with grip
PinchStrength
An assessment of the amount of force that can be applied with pinching between thumb and the 2nd and 3rd fingers.
Tenderness on joint palpation
An assessment of the amount of tenderness the participant has with palpation of the joints of interest.
Full Information
NCT ID
NCT04784065
First Posted
March 3, 2021
Last Updated
March 8, 2023
Sponsor
Baylor College of Medicine
Collaborators
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
1. Study Identification
Unique Protocol Identification Number
NCT04784065
Brief Title
A Pilot Randomized Controlled Trial for Hand Osteoarthritis
Official Title
A Pilot Randomized Controlled Trial for Hand Osteoarthritis
Study Type
Interventional
2. Study Status
Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 11, 2021 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Baylor College of Medicine
Collaborators
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a study involving people receiving care at the Michael E. DeBakey VA Medical Center, Houston Texas. We are studying people who have hand osteoarthritis (the most common form of arthritis that involves the hand) and testing treatments for the condition with the hope that we can help to improve hand pain as well as limit the damage that occurs related to the arthritis. People who choose to participate, are randomly assigned to one of two treatments, both expected to be helpful.
Detailed Description
The research will be conducted at the following location(s):
Baylor College of Medicine, Baylor St. Luke's Medical Center (BSLMC), and Michael E. DeBakey Veterans Affairs Medical Center.
Participants of this study are consented for the study, randomized into one of two treatment groups for hand osteoarthritis, both expected to improve hand symptoms. At the beginning of the study, many questionnaires, a physical exam, photographs of the hands, some x-rays, on a limited few people, and MRI will be obtained. Then the participants will be provided treatments for hand osteoarthritis based on the group wo which they were randomly assigned. One aspect of one of the treatments is viewed as experimental but the risks related to the treatment are considered to be low, so the risk-benefit ratio for participation in this study are good. We see patients in follow up more frequently during the first month, and then at 3 months and then 6 months of follow up. At the final visit, we will repeat the xrays and the MRIs.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hand Osteoarthritis
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Masking Description
The occupational therapists fabricating the orthoses used the study are the only ones not blinded in this study. The participants, principal investigator, and research assistants are all blinded to the treatment allocation.
Allocation
Randomized
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Treatment arm with control orthosis
Arm Type
Active Comparator
Arm Title
Treatment arm with experimental orthosis
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Hand orthosis
Intervention Description
An orthosis applied to a hand affected by osteoarthritis with the expectation that it will improve symptoms and possibly structural progression.
Primary Outcome Measure Information:
Title
Visual analog scale (VAS) for pain in the more symptomatic hand that includes the most symptomatic DIP joint by 24 weeks of use of traction therapy with standard of care treatment for hand OA to establish efficacy of traction therapy.
Description
An assessment of pain intensity in a given hand.
Time Frame
24 week follow up
Title
The primary structure endpoint will be change in sum of the Kellgren and Lawrence score of all Distal InterPhalangeal Joints in the hand that was placed in an orthosis over 24 weeks.
Description
An assessment of radiographic OA severity.
Time Frame
24 week follow up
Secondary Outcome Measure Information:
Title
The Functional Index for Hand Osteoarthritis (FIHOA)
Description
An assessment of hand function
Time Frame
24 week follow up
Title
The Disabilities of Arm Shoulder and Hand (DASH)
Description
An assessment of hand disability
Time Frame
24 week follow up
Title
Functional Dexterity Test
Description
An assessment of hand functional dexterity
Time Frame
24 week follow up
Title
Grip Strength
Description
An assessment of the amount of force that can be applied with grip
Time Frame
24 week follow up
Title
PinchStrength
Description
An assessment of the amount of force that can be applied with pinching between thumb and the 2nd and 3rd fingers.
Time Frame
24 week follow up
Title
Tenderness on joint palpation
Description
An assessment of the amount of tenderness the participant has with palpation of the joints of interest.
Time Frame
24 week follow up
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Enrolled to receive medical care at the Michael E. DeBakey VA Medical Center
At least 3 joints affected by distal interphalangeal (DIP) nodal hand OA
DIP nodal hand OA will be defined as Heberden's nodes on physical exam.
Sufficiently severe frequent pain of at least one DIP
Frequent pain: pain on most days of the month for at least one month in the last year.
Minimum VAS pain severity of 40 on a 0 - 100 scale
Exclusion Criteria:
History or current inflammatory arthritides (examples: gout, psoriatic arthritis, and rheumatoid arthritis)
Prior surgery on the DIP joints
Planned surgery for the DIP joints
Pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Grace H Lo, MD MSc
Phone
713-791-1414
Ext
27804
Email
ghlo@bcm.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Grace H Lo, MD MSc
Organizational Affiliation
Baylor College of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
NYU Langone
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jonathan Samuels
Facility Name
Michael E. DeBakey VA Medical Center
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Individual Site Status
Active, not recruiting
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Data from this study may be requested from other researchers 3 years after the completion of the primary endpoint by contacting Dr. Grace Lo.
IPD Sharing Time Frame
3 years after the completion of the primary endpoint
IPD Sharing Access Criteria
To be determined on a case by case basis.
Learn more about this trial
A Pilot Randomized Controlled Trial for Hand Osteoarthritis
We'll reach out to this number within 24 hrs